Bausch Health
223 hedge funds and large institutions have $2.33B invested in Bausch Health in 2023 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 71 reducing their positions, and 38 closing their positions.
10% more capital invested
Capital invested by funds: $2.13B → $2.33B (+$206M)
4.4% more ownership
Funds ownership: 73.16% → 77.56% (+4.4%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
4% less funds holding
Funds holding: 232 → 223 (-9)
15% less call options, than puts
Call options by funds: $132M | Put options by funds: $155M
16% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 38
34% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 71
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMA
Mizuho Markets Americas
New York
|
+$60.3M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$58.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$34.1M |
| 4 |
GAM
Goldentree Asset Management
New York
|
+$33.9M |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$21.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$36.1M |
| 2 |
JFG
Jefferies Financial Group
New York
|
-$25.9M |
| 3 |
GCM
Glenview Capital Management
New York
|
-$14.1M |
| 4 |
D.E. Shaw & Co
New York
|
-$12M |
| 5 |
FC
Finepoint Capital
Boston,
Massachusetts
|
-$9.32M |
BHC Hedge Fund Activity: Q3 2023 in Review
223 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2023, worth a combined $2.33B — up 9.7% from $2.13B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of BHC and 32 opened new positions — a net loss of 6 holders — while 71 trimmed existing stakes and 47 added.
The largest buyer was Mizuho Markets Americas, opening a new position worth an estimated $60.3M. The largest seller was Bank of Montreal, cutting an estimated $36.1M.
- 223 institutional investors held Bausch Health (BHC) as of Q3 2023, down from 232 in Q2 2023.
- Funds reported $2.33B of Bausch Health stock for Q3 2023, up 9.7% quarter-over-quarter.
- 32 funds opened new Bausch Health positions in Q3 2023 and 38 closed out, a net change of -6 holders.
- The largest Bausch Health buyer in Q3 2023 was Mizuho Markets Americas, an estimated $60.3M added.
- The largest Bausch Health seller in Q3 2023 was Bank of Montreal, an estimated $36.1M sold.
Based on aggregated 13F filings for Q3 2023.